Feiyi Yang

Discovery of thiapyran-pyrimidine derivatives as potential EGFR inhibitors

Zhen Xiao, Cilong Chu, Lingjia Zhou et al. · Bioorganic & Medicinal Chemistry · 2020 · 27 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +12

XS-2, a novel potent dual PI3K/mTOR inhibitor, exhibits high in vitro and in vivo anti-breast cancer activity and low toxicity with the potential to inhibit the invasion and migration of triple-negative breast cancer

Shan Xu, Xin Sun, Leixuan Luo et al. · Biomedicine & Pharmacotherapy · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +14

Synthesis, bioevaluation and molecular dynamics of pyrrolo-pyridine benzamide derivatives as potential antitumor agents in vitro and in vivo

Jianqing Zhang, Jintian Dai, Xin Lan et al. · European Journal of Medicinal Chemistry · 2022 · 18 citations

Pharmacy, Medicinal Chemistry, Oncology +10

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety

Xiaohan Hu, Sheng Tang, Feiyi Yang et al. · Molecules · 2021 · 17 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Design, synthesis and evaluation of anti-proliferative activity of 2-aryl-4-aminoquinazoline derivatives as EGFR inhibitors

Zhihui Zhou, Jie He, Feiyi Yang et al. · Bioorganic Chemistry · 2021 · 16 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12